NEW YORK CITY, NY / ACCESS Newswire / December 6, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against DexCom, Inc. ("DexCom" or the "Company") (NASDAQ:DXCM) and certain officers.â?¯â?¯ The class action, filed in the United States District Court for the Southern District of New York, and docketed under 25-cv-08912, […]
NEW YORK CITY, NY / ACCESS Newswire / December 6, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against MoonLake Immunotherapeutics ("Moonlake" or the "Company") (NASDAQ:MLTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / December 6, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Telix Pharmaceuticals Limited ("Telix" or the "Company") (NASDAQ:TLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / December 6, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against WPP Plc ("WPP" or the "Company") (NYSE:WPP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / December 6, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Marex Group Plc ("Marex" or the "Company") (NASDAQ:MRX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / December 6, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Cepton, Inc. ("Cepton" or the "Company") (NASDAQ:CPTN) and certain officers.�� The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-08571, is
NEW YORK CITY, NY / ACCESS Newswire / December 6, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against James Hardie Industries plc ("James Hardie" or the "Company") (NYSE:JHX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by
NEW YORK, Dec. 06, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of investors in cryptocurrency issued by Balancer (ticker: BAL), resulting from allegations that Balancer may have issued materially misleading business information to the investing public. SO WHAT: If
Balancer Announcement: If You Have Suffered Losses in Balancer Cryptocurrency, You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire December 06, 2025 NEW YORK, Dec. 06, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of investors
https://mma.prnewswire.com/media/2598258/THE_ROSEN_LAW_FIRM_P_A_Logo.jpg Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Synopsys, Inc. (NASDAQ: SNPS) between December 4, 2024 and September 9, 2025, both dates inclusive (the “Class Period”), of the important December 30, 2025 lead plaintiff deadline. So What: If you purchased Synopsys securities you may be entitled to